Project Grant R21HL175713
Award Date
8/1/25
Completion Date
7/31/27
Dollars Obligated
$222K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Edinburg, TX 78539, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under CFDA 93.837 - Cardiovascular Diseases Research provides $130,065 in funding to The Regents of the University of California, San Francisco (UCSF) to conduct research and mentorship activities focused on optimizing the treatment and evaluation of blood pressure for patients in safety net health systems. The key objectives are to: 1) Conduct systematic economic analyses of the costs associated with...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $165,364 to The Broad Institute, Inc. to conduct research focused on integrating novel contextual and genomic blood pressure measures to enhance cardiovascular disease prediction and management in young adults aged 18-39 years. The key objectives of this 2-year project are to: 1) identify novel ambulatory blood pressure patterns that capture dynamic responses to...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) program provides $564,445 in funding to the University of Texas Health Science Center at Houston (UTHealth) to conduct research focused on targeting hypoxia-inducible factors (HIFs) for heart and lung disease. The research program consists of three complementary projects: 1) Exploring the upstream regulation of HIFs by prolyl hydroxylase domain enzymes...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $1,371,242 to The University of Texas Rio Grande Valley to conduct research on identifying genetic and environmental factors underlying the high incidence of factor VIII inhibitors in hemophilia A patients of Mexican ancestry. The 4-year project aims to: 1) enroll and characterize a cohort of 200 severe hemophilia A patients, 2) elucidate the genetic basis of...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $717,236 to The University of Iowa to study the role of neuronal primary cilia in hypertension, autonomic dysfunction, and body fluid imbalance. The goal is to evaluate how conditional ablation of cilia in the supraoptic nucleus affects blood pressure, drinking, urine volume, sodium concentration, plasma osmolality, regional sympathetic...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $644,687 to the University of Missouri System to conduct research on a neural circuit in the brain that contributes to hypertension associated with obstructive sleep apnea. The research aims to determine how this "orexin-CRH-NTS" circuit facilitates the peripheral chemoreflex and leads to sympathoexcitation and hypertension,...
This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $190,491 to Beth Israel Deaconess Medical Center, Inc. to conduct research on plasma protein markers of the blood pressure response during exercise and their relation to incident hypertension and cardiovascular disease. The project aims to identify circulating proteins associated with exercise blood pressure that could serve as predictive markers for future...
This federal Project Grant award of $332,862.00 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research (CFDA 93.837) program, will support research to assess night-to-night variability in novel sleep disordered breathing severity metrics and their impact on daytime functioning. The study aims to characterize reliable biomarkers of obstructive sleep apnea (OSA) severity, as the current standard measure (Apnea-Hypopnea Index) underestimates...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $816,079 to the University of Texas Health Science Center at Houston to conduct proteomic profiling research on heart failure in Hispanic/Latino populations. The key objectives are to: 1) Identify circulating protein biomarkers and signatures associated with impaired cardiac function and the progression to clinical heart failure, 2)...
The federal Project Grant award R01HL176882, totaling $734,722.00, was provided by the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) to the University of Alabama at Birmingham (UAB). The award will fund a randomized clinical trial to assess the efficacy of disseminating systolic blood pressure polygenic risk scores (SBP PRS) on SBP control, adherence to a healthy lifestyle, and cardiometabolic profile among 300 hypertensive young and middle-aged U.S....